AcelRx Pharmaceuticals Alpha and Beta Analysis
| ACRXDelisted Stock | USD 1.01 0.01 1.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AcelRx Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in AcelRx Pharmaceuticals over a specified time horizon. Remember, high AcelRx Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AcelRx Pharmaceuticals' market risk premium analysis include:
Beta 1.58 | Alpha 0.37 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
AcelRx |
AcelRx Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AcelRx Pharmaceuticals market risk premium is the additional return an investor will receive from holding AcelRx Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AcelRx Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AcelRx Pharmaceuticals' performance over market.| α | 0.37 | β | 1.58 |
AcelRx Pharmaceuticals Fundamentals Vs Peers
Comparing AcelRx Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze AcelRx Pharmaceuticals' direct or indirect competition across all of the common fundamentals between AcelRx Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as AcelRx Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of AcelRx Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing AcelRx Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare AcelRx Pharmaceuticals to competition |
| Fundamentals | AcelRx Pharmaceuticals | Peer Average |
| Return On Equity | -0.51 | -0.31 |
| Return On Asset | -0.32 | -0.14 |
| Operating Margin | (28.28) % | (5.51) % |
| Current Valuation | 3.25 M | 16.62 B |
| Shares Outstanding | 16.95 M | 571.82 M |
| Shares Owned By Insiders | 2.63 % | 10.09 % |
| Shares Owned By Institutions | 38.88 % | 39.21 % |
AcelRx Pharmaceuticals Opportunities
AcelRx Pharmaceuticals Return and Market Media
The Stock received some media coverage during the period.About AcelRx Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including AcelRx or other delisted stocks. Alpha measures the amount that position in AcelRx Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
AcelRx Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of AcelRx Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AcelRx Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of AcelRx Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of AcelRx Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of AcelRx Pharmaceuticals' management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with AcelRx Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in AcelRx Stock
If you are still planning to invest in AcelRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AcelRx Pharmaceuticals' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |